Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Total Debt / Equity

Adverum Biotechnlgs Total Debt / Equity Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Total Debt / Equity from 2013 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Adverum Biotechnlgs Total Debt / Equity for the quarter ending June 06, 2020 was $11m a -49.90% decrease of -6m year over year
  • Adverum Biotechnlgs Total Debt / Equity for the last 12 months ending June 06, 2020 was $11m a -49.90% decrease of -6m year over year
  • Adverum Biotechnlgs Annual Total Debt / Equity for 2019 was $19m a 99.20% increase of 18m from 2018
  • Adverum Biotechnlgs Annual Total Debt / Equity for 2018 was $0m a -66.53% decrease of 0m from 2017
  • Adverum Biotechnlgs Annual Total Debt / Equity for 2017 was $0m a 86.19% increase of 0m from 2016
Other Ratios Metrics:
  • Adverum Biotechnlgs Total Debt / Capital for the quarter ending December 12, 2017 was $0m a 56.92% increase of 0m year over year
  • Adverum Biotechnlgs Other Liabilities for the quarter ending December 12, 2018 was $2m a -14.42% decrease of 0m year over year
View Chart On Koyfin

Quarterly ADVM Total Debt / Equity Data

06/2020$11m
03/2020$10m
12/2019$19m
09/2019$17m
06/2019$14m
03/2019$14m
12/2018$0m
12/2017$0m
09/2017$0m
06/2017$0m

Annual ADVM Total Debt / Equity Data

2019$19m
2018$0m
2017$0m
2016$0m
2012$-50m